TY - JOUR T1 - Utility of <sup>111</sup>In-Cl<sub>3</sub> scintigraphy for differentiating bone marrow reconversion JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. DO - 10.2967/jnmt.117.197913 SP - jnmt.117.197913 AU - Shoji Okuda AU - Hironori Nishibori AU - Hiroaki Hoshi Y1 - 2017/11/01 UR - http://tech.snmjournals.org/content/early/2017/11/08/jnmt.117.197913.abstract N2 - Indium chloride (111In-Cl3) scintigraphy has been used to evaluate various hematological diseases for many years. However, there have been few reports on patients with bone marrow reconversion showing high uptake in 111In-Cl3 scintigraphy. Herein, we report a case of a 68-year-old man with esophageal cancer who underwent 18F-FDG PET/CT for staging of the disease. 18F-FDG PET/CT demonstrated high uptake in the first lumbar vertebral body, which was difficult to distinguish bone metastasis and bone marrow reconversion. 111In-Cl3 scintigraphy demonstrated specific findings with high uptake in the lesion, indicating bone marrow hyperplasia or reconversion. ER -